Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants.
about
sameAs
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infantsFluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infantsIbuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infantsEthamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infantsContinuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infantsSurgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infantsFluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infantsIbuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsIndomethacin for asymptomatic patent ductus arteriosus in preterm infantsRole of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practiceOral medications regarding their safety and efficacy in the management of patent ductus arteriosusPredictors of bronchopulmonary dysplasiaClinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants.A review of the current treatment methods for posthaemorrhagic hydrocephalus of infants.Risk factors for periventricular-intraventricular hemorrhage in premature infantsA decision aid for considering indomethacin prophylaxis vs. symptomatic treatment of PDA for extreme low birth weight infants.Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatmentDiminished white matter injury over time in a cohort of premature newborns.Fluid restriction and prophylactic indomethacin in extremely low birth weight infants.Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice.Care in the early newborn period.Common clinical and practical questions on the use of intravenous Ibuprofen lysine for the treatment of patent ductus arteriosus.Patent ductus arteriosus: lack of evidence for common treatments.Conservative treatment for patent ductus arteriosus in the preterm.Cognitive outcome and cyclo-oxygenase-2 gene (-765 G/C) variation in the preterm infantIntra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques.Patent ductus arteriosus in preterm infants: do we have the right answers?Pathogenesis and prevention of intraventricular hemorrhagePotential and Limitations of Cochrane Reviews in Pediatric Cardiology: A Systematic Analysis.Pharmacological closure of the patent ductus arteriosus.Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.Towards rational management of the patent ductus arteriosus: the need for disease staging.Treating extremely low birthweight infants with prophylactic indomethacin. Evidence for short term benefits only.Patent ductus arteriosus: evidence for and against treatment.Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
P2860
Q24198805-813ED7F0-F288-4B34-88BE-F9E50DD70850Q24235346-C96D281F-7222-4F60-8B47-0C0CB5F66F0BQ24235778-22476680-59DA-4AA4-8599-96899562E05DQ24240970-EA1AC9E9-C83B-420D-B13D-5305C5141D9EQ24242285-B1410398-6AFB-41B6-A870-37DB55866D40Q24242627-78E26EEB-DA76-4C98-963A-E3598278C65EQ24242792-9801D5B4-6C3D-4193-AB48-92C3A8F688D6Q24244935-EC0D3516-CD20-4CF0-99F2-DAA896553845Q24250190-ED7041DD-2B4D-458D-A170-81C4064BF735Q24631088-DEBC5A19-6725-4D0D-A76C-4E2BEF0FF3BBQ26766965-4069C7FF-19B0-4652-94AD-06345411C80AQ26829843-A623DAD2-1473-4B30-B884-09A69E796CA7Q30433993-6E59671E-C15C-48D2-BE13-BA68BD4EF3BBQ30838863-40ECDB43-B77E-4919-A14B-BF5C7B6BB24BQ33404439-FC077AFD-5EAF-42DD-9D91-DA9B2992DA63Q33680166-13EE6D88-EB42-4094-85B1-424FA791D553Q34010218-58BABE5D-7527-4450-9086-4CF71C986F47Q34079478-9DBBE9A7-E8A9-44F2-9892-F67132147682Q34758677-113BA8BA-E6F4-410B-AB03-347621454540Q34985599-0D947224-BED3-4EA5-9CFD-BA89E6C86198Q35745155-81392EA4-5279-487F-92BF-021652DE938BQ35940529-B0D07A53-25AA-40B2-9A97-2E438727EFFFQ36290897-367AD48F-A239-4DEB-AFB1-93C6942A2818Q36977136-13BC5ADE-5E73-43CF-BED7-9B7B19DAEF03Q36977136-4B78DA7C-245C-428D-9E0A-7392260AE55EQ37174836-C2CBEA99-3AD9-44AD-92B8-F4123F54332CQ37174954-AC78493A-5AAA-4641-BA84-54F36E7C8FB3Q37233202-67296FAE-F8E0-4335-B324-F3E95F4BD5CCQ37451050-DFD1DC4F-1818-41E2-847D-7FC3C30587B1Q37585988-F83CD78F-2C94-4359-B9D5-8E8B725CC71FQ38940637-5250762B-D8E0-4E57-80FD-8B52D3C86F70Q39653317-B3BEB113-ECA5-4721-973B-CCF53E0C148BQ41860706-AED94410-F947-4D0A-87B4-0F1BB1F0B81CQ41951843-A605BE59-99C6-48F0-BCD5-19845FEBA013Q42775502-1BA84C35-E6C4-4418-9EF8-084A2991DF75Q43059447-C045E991-0487-467E-A5AF-CD468B70CBBDQ44458227-33FAB0D9-321A-413F-9A86-69A3009A6A13
P2860
Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intravenous indomethacin for p ...... very low birth weight infants.
@ast
Intravenous indomethacin for p ...... very low birth weight infants.
@en
type
label
Intravenous indomethacin for p ...... very low birth weight infants.
@ast
Intravenous indomethacin for p ...... very low birth weight infants.
@en
prefLabel
Intravenous indomethacin for p ...... very low birth weight infants.
@ast
Intravenous indomethacin for p ...... very low birth weight infants.
@en
P1476
Intravenous indomethacin for p ...... very low birth weight infants.
@en
P2093
P W Fowlie
P304
P356
10.1002/14651858.CD000174
P577
2000-01-01T00:00:00Z